Peripheral Blood Stem Cell Transplantation Clinical Trial
Official title:
Ruxolitinib and Decitabine Intensified Conditioning Regimen for Patients With High Risk Hematological Malignancies Underwenting Allogeneic Stem Cell Transplantation
The purpose of this study is to determine the efficacy and safety of Ruxolitinib and Decitabine intensified Conditioning Regimen in Patients with High Risk hematological malignancies undergoing allogeneic peripheral blood stem cell transplantation.
Allogeneic hematopoietic stem cell transplantation should be offered to eligible patients with high risk hematological malignancies whenever feasible. To further improve the outcome of transplantation patients with high risk hematological malignancies, the investigators developed a modified Bu/Cy conditioning regimen intensified by Ruxolitinib and Decitabine. In this study, the investigators tested the efficacy and feasibility of the modified Bu/Cy conditioning regimen intensified by Ruxolitinib and Decitabine in Patients with high risk hematological malignancies undergoing allogeneic peripheral blood stem cell transplantation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05436418 -
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05075681 -
Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma
|
Phase 1/Phase 2 | |
| Completed |
NCT03993639 -
KRN125 for Mobilization of Hematopoietic Stem Cells
|
Phase 2 | |
| Completed |
NCT02398708 -
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
|
||
| Completed |
NCT00575809 -
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
|
||
| Completed |
NCT00670423 -
A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation
|
Phase 1 | |
| Terminated |
NCT02326675 -
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
|
N/A | |
| Recruiting |
NCT05153226 -
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG
|
Phase 3 | |
| Recruiting |
NCT02848105 -
Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD
|
Phase 2 | |
| Not yet recruiting |
NCT03771222 -
Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies
|
Phase 2 | |
| Completed |
NCT02512679 -
Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
|
Phase 2 | |
| Recruiting |
NCT05088226 -
Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen
|
Phase 2 | |
| Recruiting |
NCT05961410 -
Eltrombopag for Peripheral Blood Stem Cell Harvest
|
Phase 2 |